🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Immunotherapy is changing resectable #gastric/GEJ #cancer care. Are you up to date? Join Yelena Y. Janjigian MD & Sam Cytryn to dive into real-world, multidisciplinary insights. 🗓️ June 16 | 7 PM EDT 🔗 bit.ly/Gastric25T

Congratulations Layal Al Mahmasani on your graduation form Memorial Sloan Kettering Cancer Center MSK Department of Medicine . It was and continues to be great honor to know you and work with you. American University of Beirut American University of Beirut Medical Center are sure also very proud of you.

Gastric cancer The Lancet doi.org/10.1016/S0140-… 👏Excellent and comprehensive summary from screening to targeted therapies by Raghav Sundar Lizzy Smyth Yelena Y. Janjigian MD Kohei shitara Hanneke van Laarhoven ESMO - Eur. Oncology

Benoit Rousseau and Luis Diaz Shared New Findings on MMR Deficient Cancers Published in Cancer Cell by Cell Press Yelena Y. Janjigian MD | Memorial Sloan Kettering Cancer Center oncodaily.com/science/benoit… #OncoDaily #Oncology #Medicine #Health #MedEd #MedX #Cancer

Watch Samuel Cytryn, MD (Sam Cytryn) & Yelena Y. Janjigian, MD* (Yelena Y. Janjigian MD) discuss the latest #GastricCancer updates - to participate, visit: bit.ly/Gastric25T x.com/i/broadcasts/1…

Dr. Jeffrey Drebin, Chair of the Department of Surgery, has been named MSK's next Chief Physician Executive. He will succeed esteemed neuro-oncologist Dr. Lisa DeAngelis who will retire this summer. In this role, Dr. Drebin will lead all clinical services and research, medical

Presentation: 2025 ASCO Progress on Non-Immunotherapy for Advanced Gastric Cancer Prof. Yelena Janjigian, Memorial Sloan Kettering Cancer Yelena Y. Janjigian MD Memorial Sloan Kettering Cancer Center

Thanks in part to funding from the Cycle for Survival community, a clinical trial led by Dr. Yelena Janjigian has shown that adding immunotherapy to chemotherapy can help prevent stomach and esophageal cancers from coming back. Learn more: bit.ly/4e9weDz

FGFR2B expression as a bookmaker in first line GEC amgen.com/newsroom/press…

Exercizumab is real. Aerobic exercise cut colon cancer recurrence + death. It’s time to combine movement with medicine not one or the other. #oncology #Cancer NEJM OncoAlert ASCO #ASCO25 DOI: 10.1056/NEJMoa2502760

This morning we spoke to Yelena Y. Janjigian MD (Memorial Sloan Kettering Cancer Center) who shared expert insights on #gastroesophagealcancer treatment at #ESMOGI25 🔬 MATTERHORN trial EFS & PRO data 🎯 Promising immunotherapy developments ⚕️ Treatment sequencing & surgical timing strategies #ESMOGI25

🧵 Yelena Y. Janjigian MD (Memorial Sloan Kettering Cancer Center) discusses key insights from the MATTERHORN study including updated EFS data and PROs 🔗tinyurl.com/5mu5crnx #ESMOGI25 ESMO - Eur. Oncology #GastricCancer #GCsm #GIsm OncoAlert This video is available on the GI Cancer Channel on VJOncology, which is

This morning at #ESMOGI25, Yelena Y. Janjigian MD chaired an education session on #gastroesophagealcancer. Discover how her research on immunotherapies to treat these cancers is changing the standard of care: bit.ly/44bZHJS Memorial Sloan Kettering Cancer Center

Very much looking forward to #ESMO25 in the 😎 city of #Berlin! Huge increase in abstract submissions, and the team is currently working hard on putting together the best scientific program for you! Make sure to join us: with my co-chair Toni Choueiri, MD FabriceAndre The Netherlands Cancer Institute OncoAlert

Novel Data and Future Challenges of Upper GI Cancers at ESMO GI 2025 - Florian Lordick piessen ESMO - Eur. Oncology Yelena Y. Janjigian MD Lizzy Smyth oncodaily.com/blog/florian-l… #ESMOGI25 #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

📢#ESMOGI2025 In Depth! Watch Yelena Y. Janjigian MD & Van Cutsem discuss the MATTERHORN results. Durvalumab + FLOT in gastric/GEJ cancer: better EFS & well tolerated; even in older or PD-L1-negative patients. 👀 Watch now bit.ly/4eJaOOa #MediMix #GastricCancer #Oncology

That feeling when 7+ years of work lands on the front page of NEJM—and one of the people I respect most, Kohei shitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn Memorial Sloan Kettering Cancer Center

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu

Looking for the latest data on #GastricCancer & #EsophagealCancer care? Drs Samuel Cytryn (Sam Cytryn) & Yelena Y Janjigian (Yelena Y. Janjigian MD) recently met to discuss treatment options in resectable disease. Click to watch! bit.ly/4mpyryt #StomachCancer #Oncology #MedEd

🎥Yelena Y. Janjigian MD (Memorial Sloan Kettering Cancer Center) shares updates in gastric & GEJ cancer at #ESMOGI25: periop strategies like MATTERHORN, HER2–PD-1 & FGFR2B targeting, and tackling IO resistance in mGC. Promising advances in a tough space. 🔗 ow.ly/80Tf50WsxVb ESMO - Eur. Oncology #STCsm #ImmunoOnc